Follow the Medicamen Biotech Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Medicamen Biotech Limited has recorded 30 reports. Market capitalisation: €3.2bn. The latest transaction was filed on 24 September 2025 (Sale). Among the most active insiders: Geetika Madan. The full history is openly available.
30
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
€3m
23 ops.
Sell Volume
10Σ signal
Buys €1m€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,907 of 29,062 companies
42.2
score / 100
Value
33
Quality
52
FCF yld-12%
Earn yld3.0%
EV/EBITDA16.1x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,500 shares@ ₹953.46747.8% of flowEquity SharesSEBI:22018b314c20cfe920a6686d7f878ae7a0b411fe
25 of 30 declarations
About Medicamen Biotech Limited
Medicamen Biotech Limited is an Indian company specializing in the manufacturing of pharmaceutical products. It operates in the healthcare and pharmaceutical sector, listed on the Bombay Stock Exchange.